163 related articles for article (PubMed ID: 37849388)
21. Identification and validation of a ferroptosis-related gene signature predictive of prognosis in breast cancer.
Liu Q; Ma JY; Wu G
Aging (Albany NY); 2021 Sep; 13(17):21385-21399. PubMed ID: 34499616
[TBL] [Abstract][Full Text] [Related]
22. An Original Ferroptosis-Related Gene Signature Effectively Predicts the Prognosis and Clinical Status for Colorectal Cancer Patients.
Shao Y; Jia H; Huang L; Li S; Wang C; Aikemu B; Yang G; Hong H; Yang X; Zhang S; Sun J; Zheng M
Front Oncol; 2021; 11():711776. PubMed ID: 34249766
[TBL] [Abstract][Full Text] [Related]
23. Construction of a ferroptosis-related five-lncRNA signature for predicting prognosis and immune response in thyroid carcinoma.
Qin Y; Zhang D; Zhang H; Hou L; Wang Z; Yang L; Zhang M; Zhao G; Yao Q; Ling R; Zhang J
Cancer Cell Int; 2022 Sep; 22(1):296. PubMed ID: 36175889
[TBL] [Abstract][Full Text] [Related]
24. A Novel Prognosis Signature Based on Ferroptosis-Related Gene DNA Methylation Data for Lung Squamous Cell Carcinoma.
Wang X; Meng Y; Liu C; Yang H; Zhou S
J Oncol; 2022; 2022():9103259. PubMed ID: 36131791
[TBL] [Abstract][Full Text] [Related]
25. Machine learning- and WGCNA-mediated double analysis based on genes associated with disulfidptosis, cuproptosis and ferroptosis for the construction and validation of the prognostic model for breast cancer.
Xu L; Wang S; Zhang D; Wu Y; Shan J; Zhu H; Wang C; Wang Q
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16511-16523. PubMed ID: 37712959
[TBL] [Abstract][Full Text] [Related]
26. Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma.
Xu Z; Peng B; Liang Q; Chen X; Cai Y; Zeng S; Gao K; Wang X; Yi Q; Gong Z; Yan Y
Front Immunol; 2021; 12():719175. PubMed ID: 34603293
[TBL] [Abstract][Full Text] [Related]
27. [Construction of a prognostic model for hepatocellular carcinoma based on pyroptosis-related genes].
Rong HC; Zhao WF; Zheng N; Guo ZH; Wang YW; Huang XP
Zhonghua Gan Zang Bing Za Zhi; 2023 May; 31(5):509-517. PubMed ID: 37365028
[No Abstract] [Full Text] [Related]
28. Construction and validation of a bladder cancer risk model based on autophagy-related genes.
Shen C; Yan Y; Yang S; Wang Z; Wu Z; Li Z; Zhang Z; Lin Y; Li P; Hu H
Funct Integr Genomics; 2023 Jan; 23(1):46. PubMed ID: 36689018
[TBL] [Abstract][Full Text] [Related]
29. Identification of novel prognostic risk signature of breast cancer based on ferroptosis-related genes.
Wang N; Gu Y; Li L; Chi J; Liu X; Xiong Y; Jiang S; Zhang W; Zhong C
Sci Rep; 2022 Aug; 12(1):13766. PubMed ID: 35962042
[TBL] [Abstract][Full Text] [Related]
30. Ferroptosis and cuproptosis prognostic signature for prediction of prognosis, immunotherapy and drug sensitivity in hepatocellular carcinoma: development and validation based on TCGA and ICGC databases.
Ma Q; Hui Y; Huang BR; Yang BF; Li JX; Fan TT; Gao XC; Ma DY; Chen WF; Pei ZX
Transl Cancer Res; 2023 Jan; 12(1):46-64. PubMed ID: 36760376
[TBL] [Abstract][Full Text] [Related]
31. A novel pyroptosis-related signature predicts prognosis and response to treatment in breast carcinoma.
Yu H; Fu Y; Tang Z; Jiang L; Qu C; Li H; Tan Z; Shu D; Peng Y; Liu S
Aging (Albany NY); 2022 Jan; 14(2):989-1013. PubMed ID: 35085103
[TBL] [Abstract][Full Text] [Related]
32. Construction of Ovarian Cancer Prognostic Model Based on the Investigation of Ferroptosis-Related lncRNA.
Yang S; Ji J; Wang M; Nie J; Wang S
Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830675
[TBL] [Abstract][Full Text] [Related]
33. Development and validation of a combined hypoxia and ferroptosis prognostic signature for breast cancer.
Zhong J; Shen X; Zhou J; Yu H; Wang B; Sun J; Wang J; Liu F
Front Oncol; 2023; 13():1077342. PubMed ID: 36998462
[TBL] [Abstract][Full Text] [Related]
34. Development and validation of a prognostic risk signature for lung adenocarcinoma constructed by six ferroptosis, necroptosis, and pyroptosis-related lncRNAs.
Peng L; Ji J; Zhang C; Wu Z; Sun Y; Fan K; Du W; Liu A; Jiao W
J Thorac Dis; 2022 Oct; 14(10):3955-3974. PubMed ID: 36389299
[TBL] [Abstract][Full Text] [Related]
35. Identification of a m
Li D; Chen T; Li QG
BMC Pulm Med; 2023 Apr; 23(1):128. PubMed ID: 37072786
[TBL] [Abstract][Full Text] [Related]
36. Identification and validation of a novel ferroptosis-related gene model for predicting the prognosis of gastric cancer patients.
Liu G; Ma JY; Hu G; Jin H
PLoS One; 2021; 16(7):e0254368. PubMed ID: 34252149
[TBL] [Abstract][Full Text] [Related]
37. Construction and validation of a 15-gene ferroptosis signature in lung adenocarcinoma.
Tu G; Peng W; Cai Q; Zhao Z; Peng X; He B; Zhang P; Shi S; Tao Y; Wang X
PeerJ; 2021; 9():e11687. PubMed ID: 34277151
[TBL] [Abstract][Full Text] [Related]
38. Establishment and validation of an aging-related risk signature associated with prognosis and tumor immune microenvironment in breast cancer.
Wang Z; Liu H; Gong Y; Cheng Y
Eur J Med Res; 2022 Dec; 27(1):317. PubMed ID: 36581948
[TBL] [Abstract][Full Text] [Related]
39. A Novel Pyroptosis-Associated Long Non-coding RNA Signature Predicts Prognosis and Tumor Immune Microenvironment of Patients With Breast Cancer.
Ping L; Zhang K; Ou X; Qiu X; Xiao X
Front Cell Dev Biol; 2021; 9():727183. PubMed ID: 34616734
[No Abstract] [Full Text] [Related]
40. Correlation between Ferroptosis-Related Gene Signature and Immune Landscape, Prognosis in Breast Cancer.
Zhu J; Chen Q; Gu K; Meng Y; Ji S; Zhao Y; Yang B
J Immunol Res; 2022; 2022():6871518. PubMed ID: 36313179
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
